|
The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients. |
|
|
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; SERVIER |
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier |
Research Funding - Amgen; Merck Serono |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Lilly; Merck Serono; Roche; Sanofi |
Research Funding - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Pierre Fabre; Roche; Sanofi; SERVIER |
Research Funding - Merck Serono; Sanofi/Aventis (Inst) |
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi |
|
|
Consulting or Advisory Role - Amgen; Bayer; Sanofi; SERVIER |
|
|
No Relationships to Disclose |
|
|
Speakers' Bureau - Amgen; AstraZeneca; Merck; SERVIER |
Travel, Accommodations, Expenses - Celgene; Ipsen; Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Guardant Health; Myriad Genetics |
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; CheckmAb; Clovis Oncology; Daiichi Sankyo; Incyte; Merck; Novartis; Roche/Genentech; Seagen |
Research Funding - MSD Oncology (Inst) |
Patents, Royalties, Other Intellectual Property - Amgen |
Travel, Accommodations, Expenses - Amgen; Bayer; Roche |
|
|
Stock and Other Ownership Interests - Bayer |
Consulting or Advisory Role - Amgen; Bayer; Celgene; Menarini; Merck Serono; Roche; Sanofi; SERVIER |
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Neophore; Phoremost |
Honoraria - Guardant Health; Illumina; Merck; Mundipharma; Novartis; Roche Pharma AG |
Consulting or Advisory Role - Biocartis; Horizon Discovery; Neophore |
Research Funding - Merck; Neophore |
Travel, Accommodations, Expenses - Biocartis |
|
|
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; BeiGene; Biocartis; Boehringer Ingelheim; Chugai Pharma; Foundation Medicine; Genentech; Genmab; HalioDx; Halozyme; Imugene; Inflection Biosciences; Ipsen; Kura Oncology; Lilly; Menarini; Merck Serono; Merrimack; Merus; Molecular Partners; MSD; Novartis; Peptomyc; Pfizer; Pharmacyclics; ProteoDesign; Rafael Pharmaceuticals; Roche; Roche; Sanofi; Seagen; Seagen; Servier; Symphogen; Taiho Pharmaceutical; VCN Biosciences |
|
|
No Relationships to Disclose |